Boc-4,5-dehydro-Leu-OH · DCHA

Online Inquiry

CAT#CP27557
CAS87720-54-5
Synonyms/Alias87720-54-5;BOC-4,5-DEHYDRO-LEU-OHDCHA;AC1MBSDY;11578_ALDRICH;11578_FLUKA;MolPort-003-725-636;BOC-4,5-DEHYDRO-LEU-OHDCHA;1385AF;KM2548;MFCD00237524;AKOS025312267;Boc-4,5-dehydro-L-leu-OH.DCHA;Boc-4,5-dehydro-Leu-OHdicyclohexylaminesalt;Boc-4,5-dehydro-L-leucinedicyclohexylaminesalt;Boc-4,5-dehydro-Leu-OHdicyclohexylammoniumsalt;Boc-4,5-dehydro-Leu-OH(dicyclohexylammonium)salt;Boc-4,5-dehydro-L-leucine(dicyclohexylammonium)salt;(S)-2-(Boc-amino)-4-methyl-4-pentenoicaciddicyclohexylaminesalt;(2S)-2-[(tert-butoxycarbonyl)amino]-4-methylpent-4-enoicacid;dicha;(S)-2-(Boc-amino)-4-methyl-4-pentenoicacid(dicyclohexylammonium)salt;N-cyclohexylcyclohexanamine;(2S)-4-methyl-2-[(2-methylpropan-2-yl)oxycarbonylamino]pent-4-enoicacid
M.F/FormulaC23H42N2O4
M.W/Mr.410.61
Quick Inquiry
×
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Customer Support & Price Inquiry

* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).

Creative Peptides has accumulated a huge library of peptide knowledge including frontier peptide articles, application of peptides, useful tools, and more!

 Myristoyl pentapeptide-7, a cosmetic peptide, is a synthetic peptide containing lysine and threonine residues, w ...

What is Trofinetide? Trofinetide is a neuropeptide synthesized from the breakdown product of insulin-like grow ...

ICl 154,129 is a new compound that shows selectivity as an antagonist of [Leu5]enkephalin and [D-AIa2, D-Leu5]en ...

What is abaloparatide? Abaloparatide (formerly known as BA058) is an investigational analog of human PTHrP (1-34) being devel ...

Anisomycin, also known by its trade name flagecidin, is a bacterial pyrrolidine antibiotic mostly isolated from ...

Contact Us

USA

Address:

Tel: |

Email:

Germany

Address:

Copyright © 2025 Creative Peptides. All rights reserved.